NLS Pharmaceutics (NLSP) Financials

$0.76

$-6.64 (-89.70%)

As on 30-Oct-2025 16:29EDT

Market cap

$4 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

--

P/B Ratio

4.8

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	-4.27	-9.68	-13.88	-14.94	-0.73	-0.19
Cash Flow from Investing Activities	0.00	--	-3.51	-0.04	0.23	-0.22
Cash from Financing Activities	5.04	1.63	17.40	20.34	0.50	0.41
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-0.47	-3.19	-10.38	-0.81	-0.24	-4.89
Cash EPS ($)	-0.47	-3.19	-10.37	-0.81	-0.24	-4.89
Adjusted Book Value ($)	0.34	--	2.06	0.04	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-1.02	-2.54	-8.73	-1.01	-0.06	-0.17
Free Cash Flow per Share ($)	-1.02	-2.54	-8.73	-1.02	-0.06	-0.17

Profitability Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	68.38	621.18	-862.92	375.85	46.80	154.54
ROE (%)	53.34	438.42	-862.92	283.03	37.76	72.70
ROA (%)	-97.10	-218.86	-219.34	-342.48	-299.94	-1,293.76
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	69.20	23.74	-30.54	-157.91	0.62	-34.17
Net Profit Growth (%)	83.73	26.21	-38.08	-317.49	47.47	-5.84
EPS Growth (%)	0.85	0.69	-11.81	-2.33	0.95	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	-4.47	-0.19	-0.12	-1.37	--	--
Price / Book Value	6.29	-0.25	0.62	30.18	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.98	-0.25	0.45	-0.92	--	--
Close Price ($)	21.10	235.96	516.00	444.00	--	--
High Price ($)	240.00	752.00	960.00	2,940.00	--	--
Low Price ($)	17.30	104.00	132.00	440.00	--	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	-0.18	--	--	-0.23	-0.14
Short term debt to equity ratio	--	-0.18	--	4,609.19	-0.20	-0.11
Current Ratio	2.69	0.23	2.75	2.38	0.03	0.09
Quick Ratio	--	--	2.76	2.40	0.04	0.10
Interest Coverage	-24.24	-81.34	-153.49	-174.08	-19.68	-5.65

Operating Efficiency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	-1,320.48	-1,277.38	-1,812.75	--	--
Payable days	283,149.59	112,168.54	65,799.57	104,368.57	--	--
Cash Conversion Cycle	--	--	--	--	--	--